| AERhB | Aminoethyl rhodamine |
| BCR | B cell receptor |
| Btk | Bruton’s kinase |
| BtkIs | Btk inhibitors |
| cGVHD | Chronic graft versus host disease |
| CLL | Chronic lymphocytic leukemia |
| COVID-19 | Coronavirus Disease 19 |
| DAC | 2,3-dialdehyde cellulose |
| EGFR | Epidermal growth factor receptor |
| MCL | Mantle cell lymphoma |
| MS | Multiple sclerosis |
| MSRR | Relapsing-Remitting Multiple Sclerosis |
| MZL | Marginal zone lymphoma |
| NP | Nanoparticles |
| NSCL | Non-Small Cell Lung Cancer |
| PH | Pleckstrin homology domain |
| PROTAC | Proteolysis targeting chimera |
| PRR | Proline-rich regions |
| RA | Rheumatoid arthritis |
| RMS | Relapsing Multiple Sclerosis |
| SH2/SH3 | Src homology 2/3 domain |
| SLE | Systemic Lupus Erythematosus |
| SLL | Small lymphocytic lymphoma |
| Syk | Spleen tyrosine kinase |
| TH | Tec homology domain |
| TK | Tyrosine kinase |
| WM | Waldenström’s macroglobulinemia |
| XLA | X-linked agammaglobulinemia |